Latest Breaking News On - Clinical surgery - Page 7 : comparemela.com

 E-Mail Boston, MA (April 30, 2021) - A new study, presented today at the AATS 101st Annual Meeting, shows significant reduction in post-operative use of Schedule II opioids for pain management following robotic surgery. To address the on-going issues of opioid overuse and abuse, the study aimed to examine the use of painkillers in Enhanced Recovery After Thoracic Surgery (ERATS) protocols and determine the impact of alternative pain management approaches on clinical outcomes. An Institutional Review Board-approved retrospective analysis of a prospectively maintained thoracic surgery database was performed on all patients undergoing elective robotic thoracic procedures from 7/1/2019 to 9/14/2020. The main pain management component of ERATS included opioid-sparing analgesics, infiltration of liposomal bupivacaine (a long-acting local anesthetic) 1:1 v/v dilution with normal saline to 9 intercostal spaces as intercostal nerve blocks and to surgical wounds as local and regional anal

United statesUniversity of miamiKarishma kodiaNestorr villamizarDaom nguyenJoanne szewczykDaom nguyen university of miamiAnnual meetingEnhanced recovery after thoracic surgeryInstitutional review board approvedClinical surgerySite disease group lungMiami healthSylvester comprehensive cancer centerAiming for schedulePain control following robotic surgery